Total raised
$2.0M
Last: Seed 2022-09
Stage
Seed
Founded
2022
Headcount
0
HQ
Rehovot
Sector
Health Tech & Life Sciences
About
OMEC.AI's mission is to help pharmaceutical companies have better chances in clinical trials by making better data-driven decisions in the pre-clinical process. The company provides an automated, data-focused solution that can produce a reliable assessment of the clinical trial-readiness of a proposed drug. OMEC.AI was established with funding and support from AION Labs, a collaboration between pharmaceutical giants Pfizer, AstraZeneca, Merck, and Teva Pharmaceuticals, together with Amazon's AWS and the Israel Biotech Fund.
Funding history · 1 round · $2.0M total
2022-09
Seed
$2.0M
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is OMEC.AI's core mission?
- OMEC.AI's mission is to enhance the success rate of clinical trials for pharmaceutical companies by enabling data-driven decisions during the pre-clinical process. The company offers an automated, data-focused solution to assess a proposed drug's clinical trial-readiness.
- When was OMEC.AI founded?
- OMEC.AI was founded in September 2022.
- What is the current operational status of OMEC.AI?
- OMEC.AI is currently inactive, having ceased operations in July 2023.
- How much funding has OMEC.AI raised in total?
- OMEC.AI has raised a total of $2,000,000 in funding. For a full financing history, please refer to startupim.
- Which organizations provided initial funding and support for OMEC.AI?
- OMEC.AI was established with funding and support from AION Labs and the Israel Innovation Authority. AION Labs is a collaboration involving Pfizer, AstraZeneca, Merck, Teva Pharmaceuticals, and Amazon's AWS.
- Who are the founders of OMEC.AI?
- The founders of OMEC.AI are Ori Shachar and Amir Harel.
- In which city is OMEC.AI headquartered?
- OMEC.AI is headquartered in Rehovot, Israel.
- What technology does OMEC.AI primarily utilize?
- OMEC.AI primarily utilizes Artificial Intelligence in its solutions.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial Intelligence
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesLife SciencesPharmaceuticals
Business model
B2C
Tags
biopharmaceuticalartificial-intelligenceclinical-trialsdrug-developmentdrug-discovery